We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Tests to Detect Common Immune Signature in Blood of COVID-19 Patients Could Predict Severity of Disease

By LabMedica International staff writers
Posted on 21 Aug 2020
Print article
Illustration
Illustration
Researchers have found a common immune signature in the blood of patients with COVID-19, which could be used to predict how severely ill a patient will become, thereby aiding patient management.

The team of researchers at the Francis Crick Institute (London, UK), King’s College London (London, UK) and Guy's and St Thomas' NHS Foundation Trust (London, UK) analyzed blood samples from 63 patients with SARS-CoV-2. Among several molecules expressed at atypical levels in the blood of patients, the researchers identified three in particular that could indicate how the disease will progress - what the researchers are calling the “triad”, made up of IP-10, interleukin-10 and interleukin-6. Patients with COVID-19 who displayed measurably higher levels of these molecules when first admitted to hospital went on to become more severely ill. The triad was found to be a more rigorous predictor of disease severity than commonly-used clinical indicators, including C-reactive protein (CRP), D-dimer or ferritin.

In addition, they found that within their patient cohort, measuring levels of IP-10 in blood taken on the first day in hospital was the most accurate way to date of predicting how long the patient would remain in hospital. The researchers are now looking to new collaborators to help develop robust, easily applied tests for these molecules. Since their preliminary analysis carried out in May, the team has now compared the immune signatures of COVID-19 patients with 10 age-matched patients who had non-COVID-19 lower respiratory tract infections. They found that high levels of the triad were not seen in those patients, suggesting this feature, in combination with other traits, may form a core COVID-19 immune signature. As well as continuing to monitor the immune response of patients in hospital, the team are also using these blood samples to gain further insights into the disease and are part of PHOSP (Post-HOSPitalisation COVID-19 study), a national consortium working to understand and improve long-term health outcomes for patients who were hospitalized with COVID-19.

“As we approach the upcoming winter flu season, along with the threat of resurgent cases of COVID-19, it is possible that our hospitals will come under great pressure. To handle this, we need to equip our doctors with the tools to make informed judgements about which patients are likely to improve and who might need more urgent care,” said Project lead Adrian Hayday, who heads the Crick’s Immunosurveillance Laboratory and is Professor of Immunobiology at King’s College London.

Related Links:

Francis Crick Institute
King’s College London
Guy's and St Thomas' NHS Foundation Trust
Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Automated Blood Typing System
IH-500 NEXT
New
Rocking Shaker
HumaRock
New
Toxoplasma Gondii Test
Toxo IgG ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.